PFIZER INC Accrued Income Taxes, Noncurrent
PFIZER INC (PFE) had Accrued Income Taxes, Noncurrent of $7.02 billion as of 2013-09-29, per its 10-Q filed 2013-11-08.
Discontinued › Notes
us-gaap:AccruedIncomeTaxesNoncurrent · last filed 2013-11-08
- 2013-09-29: Accrued Income Taxes, Noncurrent $7.02B.
- 2013-06-30: Accrued Income Taxes, Noncurrent $6.82B.
- 2013-03-31: Accrued Income Taxes, Noncurrent $6.76B.
- 2012-12-31: Accrued Income Taxes, Noncurrent $6.58B; Accrued Income Taxes, Noncurrent as first filed $6.61B.
| Period end | Accrued Income Taxes, Noncurrent | Accrued Income Taxes, Noncurrent as first filed |
|---|---|---|
| 2013-09-29 | $7.02B 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $6.82B 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $6.76B 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $6.58B 10-Q · filed 2013-11-08 | $6.61B 10-K · filed 2013-02-28 |
| 2012-09-30 | $6.01B 10-Q · filed 2012-11-09 | |
| 2012-07-01 | $7.10B 10-Q · filed 2012-08-09 | |
| 2012-04-01 | $6.98B 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $6.89B 10-K · filed 2013-02-28 | |
| 2011-10-02 | $6.90B 10-Q · filed 2011-11-10 | |
| 2011-07-03 | $6.83B 10-Q · filed 2011-08-11 | |
| 2011-04-03 | $6.59B 10-Q · filed 2011-05-12 | |
| 2010-12-31 | $6.25B 10-K · filed 2012-02-28 | |
| 2010-10-03 | $8.58B 10-Q · filed 2010-11-12 | |
| 2010-07-04 | $9.54B 10-Q · filed 2010-08-12 | |
| 2010-04-04 | $8.34B 10-Q · filed 2010-05-13 | |
| 2009-12-31 | $9.00B 10-K · filed 2011-02-28 | |
| 2009-09-27 | $6.84B 10-Q · filed 2009-11-05 | |
| 2009-06-28 | $7.03B 10-Q · filed 2009-08-06 | |
| 2008-12-31 | $6.57B 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |